For appointments, please call:
(303) 823-4882
A single sub-psychotomimetic dose of ketamine, an ionotropic glutamatergic n-methyl-d-aspartate (NMDA) receptor antagonist, produces a fast-acting antidepressant response in patients suffering from major depressive disorder. Depressed patients report alleviation of core symptoms within two hours of a single low-dose intravenous infusion of ketamine with effects lasting up to two weeks. The rapidity of ketamine action...
We were honored to be recently featured recently in The Denver Post, at https://www.denverpost.com/2022/12/24/ketamine-infusions-depression-chronic-pain-colorado. It is always beneficial when…
Measures to contain the spread of coronavirus have inadvertently increased teen depression and suicide risk, as demonstrated by Mayne…
A recent study[1] published in the January 5, 2021 American Journal of Psychiatry by Dr. Adriana Feder and her…
Ketamine continues to gain recognition, by both lay public and medical professionals, as a remarkably effective antidepressant, with minimal…
Many of our ketamine therapy patients tell us that the COVID-19 pandemic is causing a dramatic increase in their…